LETTER TO THE EDITOR
Activin as a promising test in differential diagnosis of chronic liver diseases
First published: 04 May 2012
Levent Filik, Associate Professor of Gastroenterology, Ankara Research Hospital, Gastroenterology Clinic, Ankara, 06600, Turkey. Tel.: 0903125954272; fax: 00903125954272; e-mail:
[email protected] No abstract is available for this article.
References
- 1
Voumvouraki A,
Notas G,
Koulentaki M,
Georgiadou M,
Klironomos S,
Kouroumalis E.
Increased serum activin-A differentiates alcoholic from cirrhosis of other aetiologies.
Eur J Clin Invest
2012; doi: 10.1111/j.1365-2362.2012.02647.x.
- 2
Kowdley KV,
Belt P,
Wilson PA,
Yeh MM,
Neuschwander-Tetri BA,
Chalasani N
et al.
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.
Hepatology
2012; 55(1): 77–85.
